These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24872956)

  • 1. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.
    Liu X; Ye H; Li L; Li W; Zhang Y; Zhang JY
    J Immunol Res; 2014; 2014():326593. PubMed ID: 24872956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.
    Liu W; Li Y; Wang B; Dai L; Qian W; Zhang JY
    Scand J Immunol; 2015 Jun; 81(6):502-7. PubMed ID: 25721883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer.
    Liu W; Li Z; Xu W; Wang Q; Yang S
    Scand J Immunol; 2013 Apr; 77(4):255-60. PubMed ID: 23421499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
    Li Y; Francia G; Zhang JY
    Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Nishioka M; Tan EM
    Int J Oncol; 2005 Feb; 26(2):311-7. PubMed ID: 15645114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.
    Yi YC; Wang SC; Chao CC; Su CL; Lee YL; Chen LY
    J Clin Lab Anal; 2010; 24(5):357-62. PubMed ID: 20872572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.
    Hammer NA; Hansen Tv; Byskov AG; Rajpert-De Meyts E; Grøndahl ML; Bredkjaer HE; Wewer UM; Christiansen J; Nielsen FC
    Reproduction; 2005 Aug; 130(2):203-12. PubMed ID: 16049158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
    Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
    Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
    Kessler SM; Lederer E; Laggai S; Golob-Schwarzl N; Hosseini K; Petzold J; Schweiger C; Reihs R; Keil M; Hoffmann J; Mayr C; Kiesslich T; Pichler M; Kim KS; Rhee H; Park YN; Lax S; Obrist P; Kiemer AK; Haybaeck J
    Oncotarget; 2017 Oct; 8(52):89736-89745. PubMed ID: 29163784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
    Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY
    Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
    Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seromic profiling of ovarian and pancreatic cancer.
    Gnjatic S; Ritter E; Büchler MW; Giese NA; Brors B; Frei C; Murray A; Halama N; Zörnig I; Chen YT; Andrews C; Ritter G; Old LJ; Odunsi K; Jäger D
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5088-93. PubMed ID: 20194765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
    Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY
    Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.
    Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X
    Front Immunol; 2021; 12():698312. PubMed ID: 34489945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of IGF2 mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival.
    Barghash A; Helms V; Kessler SM
    Scand J Immunol; 2015 Aug; 82(2):142-3. PubMed ID: 25916626
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.